Phosphodiesterase Inhibitor (Sildenafil) in the Management of Honey Moon Impotence

Muhammad Malik; Zahid Iqbal; Naveed Ashraf; Safdar Javed; Iftikhar Ahmed

Nephro-Urology Monthly

Current Issue All Issues In Press Search Accepted Manuscripts

Journal Information Boards and Committees Indexing and Listing Sources Publication Ethics and Malpractice Statement Support Reviewer and AE Registration Form Contact Us Journal Metrics Open Peer Review (OPR)

APC

Authors Guide Submit Manuscript

Phosphodiesterase Inhibitor (Sildenafil) in the Management of Honey Moon Impotence

Author(s):

Muhammad Akram Malik

^1,*,

Zahid Iqbal²,

Naveed Ashraf²,

Safdar Hassan Javed²,

Iftikhar Ahmed²

1Department of Urology and Renal Transplantation, Madina Teaching Hospital/University Medical college, [email protected], Pakistan

2Department of Urology and Renal Transplantation Allied Hospital, Pakistan

Nephro-Urology Monthly:Vol. 1, issue 2; 103-107

Published online:Dec 31, 2009

Article type:Research Article

Received:Mar 27, 2009

Accepted:May 30, 2009

How to Cite:Malik M, Iqbal Z, Ashraf N, Javed S, Ahmed I. Phosphodiesterase Inhibitor (Sildenafil) in the Management of Honey Moon Impotence. Nephro-Urol Mon. 2009;1(2):. doi:

Abstract

Background and Aims: Honeymoon impotence or first night erectile dysfunction (ED) is one kind of psychogenic ED which is not uncommon. Prevalence of this kind of ED is higher in conservative communities especially the Muslim population. We assessed the role of Sildenafil, a phosphodiesterase inhibitor (PDE-5) in the management of honeymoon (psychogenic) impotence.

Methods: All patients having erectile dysfunction (ED) after marriage with normal nocturnal erections were enrolled in this prospective study from 01-09-2006 to 31-08-2008. Reassurance & Sildenafil 100 mg at bed time was given to every patient and dose reduced to 50 mg after 3 successful intercourses. Patients who did not respond to PDE-5 inhibitor (3 doses), were given intracavernosal injection alprostadil and shifted to PDE-5 inhibitor after successful intercourse.

Results: Total number of patients was 45 with age range of 20-39 years. Mean duration elapsed before seeking medical advice was 10±14 days. Eighty percent patients had successful intercourse on first dose of Sildenafil with 95% confidence interval (CI) and 13% patients responded to 2^nd dose of Sildenafil. Twelve percent patients suffered mild, well tolerable complications.

Conclusions: Honeymoon impotence is not an uncommon condition in some special population. Sildenafil proved to be effective, with high success rate and few tolerable complications.

Keywords

Honey Moon Impotence

Erectile Dysfunction

Phosphodiesterase Inhibitors (PDE-5)

Alprostadil

Full Text

Full text is available in PDF

Import into EndNote Import into BibTex

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 0
Last Update: 3 weeks ago
Scopus by Title: 0
Last Update: 3 weeks ago
Scopus by Title (Ref): 2
Last Update: 3 weeks ago
CrossRef: 0
Last Update: 4 days ago

Metrics

Purchasing Reprints

Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.

Search Relations

Author(s):

Muhammad Malik:[PubMed][Scholar]
Zahid Iqbal:[PubMed][Scholar]
Naveed Ashraf:[PubMed][Scholar]
Safdar Javed:[PubMed][Scholar]
Iftikhar Ahmed:[PubMed][Scholar]

Outlines

Phosphodiesterase Inhibitor (Sildenafil) in the Management of Honey Moon Impotence

Abstract

Full Text

Last Update: 3 weeks ago

Last Update: 3 weeks ago

Last Update: 3 weeks ago

Last Update: 4 days ago